Puma Biotechnology (PBYI) Work In Process (2020 - 2026)

Puma Biotechnology's Work In Process history runs 7 years deep, the most recent figure standing at $1.9 million for Q1 2026.

• Quarterly Work In Process rose 80.36% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (up 80.36% YoY) and the FY2025 annual result came in at $1.3 million, up 77.18% from the prior year.
• Work In Process was $1.9 million for Q1 2026 at Puma Biotechnology, up from $1.3 million in the prior quarter.
• Across five years, Work In Process topped out at $7.8 million in Q2 2024 and bottomed at $758000.0 in Q4 2024.
• A 5-year average of $2.5 million and a median of $2.0 million in 2024 frame the typical range for Work In Process.
• Peak annual rise in Work In Process reached 169.08% in 2025, while the deepest fall reached 82.89% in 2025.
• Puma Biotechnology's Work In Process stood at $2.7 million in 2022, then slumped by 69.18% to $820000.0 in 2023, then decreased by 7.56% to $758000.0 in 2024, then surged by 77.18% to $1.3 million in 2025, then surged by 43.56% to $1.9 million in 2026.
• Business Quant data shows PBYI's Work In Process at $1.9 million in Q1 2026, $1.3 million in Q4 2025, and $5.4 million in Q3 2025.